Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cancer activist joins CNN medical correspondent for colon cancer research benefit event

Legendary journalist, best-selling author and cancer activist Katie Couric joins CNN's Sanjay Gupta, M.D. Nov. 1 for the fifth annual A Conversation With a Living Legend® luncheon benefiting The University of Texas MD Anderson Cancer Center.

15 Oct 2011

Research roundup: Racial disparities in colon cancer survival; Options to cut health spending; Covering teenagers

Survival Disparities In African American And White Colo-Rectal Cancer Patients -- Researchers analyzed results from 12 controlled clinical trials to understand disparities between black and white survivors of colorectal cancer.

14 Oct 2011

JCO publishes Keryx's KRX-0401 Phase 1 / 2 combination study on advanced MM

Keryx Biopharmaceuticals, Inc. today announced that a manuscript entitled "Perifosine Plus Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated with Bortezomib: Results of a Multicenter Phase l/2 Trial" reporting Phase 1 / 2 combination activity of KRX-0401 (perifosine) in the treatment of advanced multiple myeloma (MM) patients, was selected for publication in the October 11, 2011 online edition of the Journal of Clinical Oncology.

14 Oct 2011

SFDA approves China Medical Technologies' colorectal cancer assay

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that China's State Food and Drug Administration has approved the Company's real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog assay as a companion diagnostic test for the use of a targeted drug for the treatment of colorectal cancer patients.

13 Oct 2011

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

A new study from Spain finds that narrow band imaging appears to be a less time-consuming and equally effective alternative to chromoendoscopy for the detection of dysplasia (abnormal growths) in patients with long-standing inflammatory bowel disease.

13 Oct 2011

EMA recommends 4SC's resminostat for orphan medicinal product designation to treat HL

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced that the European Medicines Agency (EMA) has recommended 4SC's anti-cancer compound resminostat for designation as orphan medicinal product for the treatment of Hodgkin's Lymphoma (HL), a cancer of the lymphatic system.

13 Oct 2011

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts General Hospital Cancer Center, Boston, has now identified a potential way to effectively use receptor tyrosine kinases inhibitors to treat individuals with KRAS mutant colorectal cancers - combine them with inhibitors of the MEK/ERK signaling pathway.

11 Oct 2011

MD Anderson initiates orders of Cesium-131 to help control intermediate risk prostate cancer

IsoRay Inc., a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that MD Anderson Cancer Center has initiated orders of Cesium-131 brachytherapy (internal radiation therapy) seeds as it continues its clinical research study investigating brachytherapy's ability to help control intermediate risk prostate cancer.

11 Oct 2011

NCI selects UT Southwestern, Parkland to improve colorectal cancer screening

The National Cancer Institute (NCI) has selected UT Southwestern Medical Center and Parkland Health & Hospital System as a national site to improve screening for colorectal cancer, the nation's No. 3 cancer killer.

10 Oct 2011

Report on cancer survivorship statistics

Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent.

7 Oct 2011

Co-occurrence of medical and psychiatric disease is likely to affect QoL

This review provides evidence of a substantially reduced psychosocial and physical quality of life in medically ill patients with comorbid mental disorders. This patient-reported outcome highlights the importance of recognizing and treating comorbid mental disorders in the medically ill.

7 Oct 2011

More than three-quarters of cancer patients have vitamin D deficiency

More than three-quarters of cancer patients have insufficient levels of vitamin D (25-hydroxy-vitamin D) and the lowest levels are associated with more advanced cancer, according to a study presented on October 2, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

4 Oct 2011

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

The University of Alabama at Birmingham Comprehensive Cancer Center has received a five-year, $27.5 million Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016.

1 Oct 2011

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Circadian Technologies Limited is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate clinical studies of VGX-100.

1 Oct 2011

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company's leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

30 Sep 2011

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.

29 Sep 2011

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Cancer activist joins CNN medical correspondent for colon cancer research benefit event

Research roundup: Racial disparities in colon cancer survival; Options to cut health spending; Covering teenagers

JCO publishes Keryx's KRX-0401 Phase 1 / 2 combination study on advanced MM

SFDA approves China Medical Technologies' colorectal cancer assay

Narrow band imaging an equally effective alternative to chromoendoscopy for dysplasia

EMA recommends 4SC's resminostat for orphan medicinal product designation to treat HL

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

MD Anderson initiates orders of Cesium-131 to help control intermediate risk prostate cancer

NCI selects UT Southwestern, Parkland to improve colorectal cancer screening

Report on cancer survivorship statistics

Co-occurrence of medical and psychiatric disease is likely to affect QoL

More than three-quarters of cancer patients have vitamin D deficiency

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

New study recommends colorectal cancer screening from age of 45 for men

VHI releases report on HMO quality and satisfaction

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Men need colon cancer screening earlier than women: Study

Mastering RNA extraction for plant and fungal research – eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in